Sickle cell disease and gene editing

Before the end of 2023, I had rarely heard of sickle cell disease (or anaemia). I knew it existed, but that was all. Then, around November and December, it was suddenly in the media spotlight, because UK and US health authorities approved a new therapy and because the new therapy used the still new and …

Gene editing, gene shears and other titbits from the history of genetic engineering

I was wondering what to write about. In past blogs, I have done quite a bit of ‘conceptual history’ about metaphors or phrases like ‘imaginaries’, ‘tipping points’, ‘deficit model’, ‘trickle down economics’ and even ‘gene surgery‘ and ‘gene drive’. I have also written a few posts about gene editing or genome editing. But, come to …

Human genome editing summit, London, 2023

Ceci n’est pas un blog post. As I have no time to write anything proper for a few weeks, these are just some notes and pointers. This non-post is ‘about’ the Third International Summit on Human Genome Editing which took place at The Francis Crick Institute in London from 6 to 8 March. I couldn’t …

Gene drive communication: On bombs and bullets

In a recent article for Scientific American, the zoologist and author of a recent book on the history of genetic engineering, Matthew Cobb, lays out the pros and cons of ‘gene drive’. Gene drive is a new genetic technology that could be used to wipe out whole species of insects that transmit, for example, malaria. …

Making Science Public 2021: End of year round-up of blog posts

We are coming to the end of a another pandemic year, and time seems to expand endlessness towards an uncertain horizon. That means quite a few of my blog posts this year were still devoted to covid and the pandemic, but I also wrote about genetics, climate change and some other incidental topics. As usual, …

Post-Brexit gene editing regulation

Some of us are old enough to remember the controversies surrounding genetically modified or engineered foods and crops that raged in Europe (which included the UK) around the turn of the millennium. Some of us are even old enough to remember debates about recombinant DNA in the seventies (for those who don’t, I recommend Matthew …

Genetics and genomics – when metaphors begin to matter

I remember in the not so distant past standing in the Wellcome Sanger Institute in Cambridge admiring the huge sequencing machines and chatting about public engagement with colleagues before giving a talk about genomics and metaphors. I also remember writing some things about gene editing and metaphor. In my mind all this related to basic …

CRISPR, the Nobel, and women in science

I wrote my first blog post about CRISPR, gene editing or genome editing on 24 March 2015. It was entitled “From recombinant DNA to genome editing: A history of responsible innovation?” And I have written quite a few more blog posts about this new biotechnology since then. I knew that sometimes in the distant future …

Inspecting Pandora’s box: Promises and perils of gene drives

This is a guest post by Aleksandra Stelmach, University of Nottingham, Institute for Science and Society. *** Some years ago the sociologist Alan Petersen noted that metaphors of new biotechnologies not only express hopes and fears about their use and misuse, but that they also set the agenda for debate and action. Thus, metaphors not …

CRISPR culture

CRISPR is a way of changing and replacing parts of DNA using enzymes like a pair of molecular scissors (of course things are more complex than this!). This new technology for ‘editing’ DNA, genes or genomes began to attract public attention between around 2012 and 2015. When I started to write about metaphors used to …